 |  | |
 |
|
| Educational background |
| |
M.D., Faculty of Medicine University of the West Indies, 1969
Residency, Lemuel Shattuck Hospital
Fellowship, New England Medical Center
|
|
| Areas of expertise |
| |
| Antineoplastic Agents | Tumor Markers, Biological |
| Family | Tumor Necrosis Factor-alpha |
| Cytokines | Antineoplastic Combined Chemotherapy Protocols |
| Adrenal Cortex | Adenocarcinoma |
| Decision Theory | Bromocriptine |
| Interferon-alpha | Aromatase |
| Fadrozole | Colorectal Neoplasms |
| BCG Vaccine | Otorhinolaryngologic Neoplasms |
| Platelet Factor 4 | Receptor, Epidermal Growth Factor |
| Aldosterone | Lung Neoplasms |
| Research Design | Enzyme Inhibitors |
| Interleukin-2 | Adjuvants, Immunologic |
| Hypercalcemia | Neoplasms, Hormone-Dependent |
| Triazoles | Nitriles |
| Health Services Needs and Demand | Diphosphonates |
| Carcinoma, Small Cell | Health Services Research |
| Carcinoma, Squamous Cell | Menopause |
| Prostatic Neoplasms | Randomized Controlled Trials as Topic |
| Receptor, erbB-2 | Tomography, X-Ray Computed |
| Antineoplastic Agents, Hormonal | Mopidamol |
| Pyrimidines | Breast Neoplasms |
| Anti-Inflammatory Agents, Non-Steroidal | Bone Neoplasms |
| Terminal Care | Imidazoles |
| Interferon-gamma, Recombinant | Somatostatin |
| Clinical Trials as Topic | Coagulants |
| Eflornithine | Hormones |
| Pancreatic Neoplasms | Skin Neoplasms |
| Melanoma | Mineralocorticoids |
| Estrogens | Propionibacterium acnes |
| Antibodies, Monoclonal | Hepatic Artery |
| Neoplasms | Bias (Epidemiology) |
| Liver Neoplasms | CA-15-3 Antigen |
| Antigens, Neoplasm | Extracellular Space |
| Proto-Oncogene Proteins | Receptors, Cell Surface |
| 2',5'-Oligoadenylate Synthetase | Gene Expression Regulation, Enzymologic |
| Leukocytes, Mononuclear | Platelet-Derived Growth Factor |
| Androgens | Glucocorticoids |
| Progestins | Interferon Alfa-2a |
| Aminoglutethimide | Hydrocortisone |
| Airway Obstruction | Laryngeal Neoplasms |
| Lymphoma | Tracheal Neoplasms |
| Fluoxymesterone | Palliative Care |
| Carcinoma, Renal Cell | Kidney Neoplasms |
| Amino Acids | Apoptosis |
| Estrogen Antagonists | Proto-Oncogene Proteins c-bcl-2 |
| Tamoxifen | Osteolysis |
| Neoplasm Metastasis | Antigens |
| Megestrol | Carcinoma |
| Estradiol | Gonadotropin-Releasing Hormone |
| Tissue Extracts | Hematologic Diseases |
| Interferon Type I | Interferon Type II |
| Ornithine | Mitolactol |
| Thrombophlebitis | Ambulatory Care |
| Health Expenditures | Carcinoembryonic Antigen |
| Glycoproteins | Neoplasm Proteins |
| Gonadal Steroid Hormones | Adrenalectomy |
| Intestinal Neoplasms | Bleomycin |
| Cisplatin | Head and Neck Neoplasms |
| Methotrexate | Hearing Disorders |
| Temporal Bone | Bacterial Vaccines |
| Propionibacterium | Data Collection |
| Receptors, Estrogen | Anthraquinones |
| Indomethacin | Parathyroid Hormone |
| Prostaglandins E | Adjuvants, Pharmaceutic |
| Aspirin | Blood Platelets |
| Colonic Neoplasms | Rectal Neoplasms |
| Raynaud Disease | Vinblastine |
| Sialic Acids | Hypophysectomy |
| Blood Proteins | Ovarian Neoplasms |
| Chlorambucil | Diethylstilbestrol |
| Carcinoma, Intraductal, Noninfiltrating | Pancytopenia |
| Aminopyrine | Cyclophosphamide |
| Immunotherapy | Liver |
| Anticonvulsants | Breath Tests |
| Diazepam | Liver Diseases |
| Teratoma | Testicular Neoplasms |
| Hypersensitivity, Delayed | Uterine Cervical Neoplasms |
| Uterine Neoplasms | Hypersensitivity, Immediate |
| Polyamines | Gallium Radioisotopes |
| Radionuclide Imaging | Thrombosis |
| Gastrointestinal Neoplasms | Neoplasm Recurrence, Local |
| Growth Substances | Narcotics |
| Collagen | Peptides |
| Soft Tissue Neoplasms | Bone Resorption |
| Aromatase Inhibitors | |
|
|
| Publication author name |
|
| Select publications |
|
|
|
|
|
